383 filings
Page 5 of 20
SC 13G
hbn10
27 Jan 20
Nanoviricides, Inc.
12:11pm
SC 13G/A
qrwpqc0ijzigg
24 Jan 20
Nanoviricides, Inc.
4:12pm
424B1
opkics635neusd
23 Jan 20
Prospectus with pricing info
9:04pm
EFFECT
kliyfdunk8e3m0
10 Jan 20
Notice of effectiveness
12:15am
CORRESP
5vo4v
9 Jan 20
Correspondence with SEC
12:00am
CORRESP
puncq 6awm5
8 Jan 20
Correspondence with SEC
12:00am
8-K/A
2j4l8
2 Jan 20
Entry into a Material Definitive Agreement
12:39pm
8-K
jrt91b
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
FWP
qsqgqu ipon1g393
17 Dec 19
Free writing prospectus
12:00am
8-K
03tm rm11kj5vdu
13 Dec 19
NanoViricides President Dr. Anil Diwan Provides Responses to Shareholder Questions at the Annual Meeting of Shareholders
5:19pm
UPLOAD
eru7r5 ovroz78
9 Dec 19
Letter from SEC
12:00am
NT 10-Q
d7jhof
14 Nov 19
Notice of late quarterly filing
1:55pm
8-K
yjz5 25id3cz
5 Nov 19
NanoViricides Completes Licensing for VZV Field which Includes Shingles Drug Development
9:39pm
RW
sklooz9 5yhxewrf81
5 Nov 19
Registration withdrawal request
9:32pm